MedPath

Effect of combined probiotic and selenium supplementation in treatment of coronary heart disease

Phase 3
Conditions
I25.9
Coronary Heart Disease.
Chronic ischemic heart disease, unspecified
Registration Number
IRCT20170513033941N28
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion Criteria: patients diagnosed with type 2 diabetes and coronary heart disease.
Individuals aged 45-85 years.

Exclusion Criteria

Exclusion Criteria: Selenium, probiotic and/or synbiotic consumption within the last 3 months
Patients with thyroid disorders
Severe renal insufficiency and hepatic failure
Experiencing an acute myocardial infarction and cardiac surgery within the past 3 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Calculation using HOMA formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath